| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 04/09/2003 | CN1105184C Enzyme with protease activity |
| 04/09/2003 | CN1104907C Vibrio cholerae 01 (CVD111) and Non-01 (CVD112 and CVD112 RM) serogroup vaccine strain and methods of making same |
| 04/09/2003 | CN1104844C Oral composition for animals |
| 04/08/2003 | US6545142 Primers; nucleotide sequence |
| 04/08/2003 | US6545141 Brain-specific adapter molecule, gene thereof, and antibody thereto |
| 04/08/2003 | US6545124 Antiproliferative agents |
| 04/08/2003 | US6544948 ΔP62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer |
| 04/08/2003 | US6544774 Morphological mutants of filamentous fungi |
| 04/08/2003 | US6544767 Genetic engineering; isolated polypeptide |
| 04/08/2003 | US6544733 Method of identifying non-host plant disease resistance genes |
| 04/08/2003 | US6544731 Genetic engineering; binding antibodies |
| 04/08/2003 | US6544519 Polypeptide originating in haemophilus paragallinarum and process for producing the same |
| 04/08/2003 | US6544510 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 04/08/2003 | US6544509 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 04/08/2003 | US6544508 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) |
| 04/08/2003 | CA2191344C Synthetic peptide analogs of lung surfactant protein sp-c |
| 04/08/2003 | CA2163524C Assay and reagents for identifying anti-proliferative agents |
| 04/08/2003 | CA2127470C Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis |
| 04/08/2003 | CA2109193C Gaba-a receptor subunits (.alpha.-2,.alpha.-3,.alpha.-5,.alpha.-6,.beta.-2) and transfected cells expressing them |
| 04/08/2003 | CA2079364C Process for production of dihomo-y-linolenic acid and lipid containing same |
| 04/04/2003 | WO2002029063A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same |
| 04/04/2003 | CA2424877A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same |
| 04/03/2003 | WO2003027302A1 Process for producing pravastatin sodium salt using streptomyces flavidovirens dsm 14455 |
| 04/03/2003 | WO2003027294A1 Glucose dehydrogenase |
| 04/03/2003 | WO2002010420A3 Silicatein-mediated synthesis of amorphous silicates and siloxanes and use thereof |
| 04/03/2003 | US20030064501 Genetically engineered bacteria for use in the generation of preferential tripeptide milk product |
| 04/03/2003 | US20030064500 Method for continuous cultivation of microorganisms of the genus eremothecium |
| 04/03/2003 | US20030064499 Enzymatic polypeptide for use in the design of viricides |
| 04/03/2003 | US20030064431 Complement receptor type 1 (cr1)-like sequences |
| 04/03/2003 | US20030064078 Vaccines |
| 04/03/2003 | US20030064065 35 kappaD tumor associated protein antigen: uses and methods detection |
| 04/03/2003 | CA2461755A1 Glucose dehydrogenase |
| 04/02/2003 | EP1298216A1 Process for treating with enzyme |
| 04/02/2003 | EP1298215A2 Recombinant production of immunologically reactive truncated CMV glycoprotein H |
| 04/02/2003 | EP1298212A2 Method for cloning and expression of BsmBI restriction endonuclease and BsmBI methylase in E. coli and purification of BsmBI endonuclease |
| 04/02/2003 | EP1298211A2 Polynucleotide segment of HPV16 Genome |
| 04/02/2003 | EP1298208A2 Ribozymes targeting a hiv tat sequence |
| 04/02/2003 | EP1298203A2 Diagnosis and treatment of autoimmune diseases |
| 04/02/2003 | EP1298200A2 L-Cysteine producing bacterium and method for producing l-cysteine |
| 04/02/2003 | EP1298199A2 Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids |
| 04/02/2003 | EP1298144A2 Murine monoclonal anti-idiotype antibody 3H1 |
| 04/02/2003 | EP1297837A1 Remedies for allergic diseases and process for producing the same |
| 04/02/2003 | EP1297187A2 Method for the detection of influenza a/b viruses |
| 04/02/2003 | EP1297171A1 Microbial production of r-phenylacetylcarbinol by biotransformation of benzaldehyde by filamentous fungi |
| 04/02/2003 | EP1297170A1 Method for stable chromosomal multi-copy integration of genes |
| 04/02/2003 | EP1296989A2 Polycyclic xanthones as antibiotics |
| 04/02/2003 | EP1296932A1 Use of compositions consisting of cationic compounds and proton donors for stabilising and/or isolating nucleic acids in or from micro-organisms such as prokaryots, fungi, protozoa or algae |
| 04/02/2003 | EP1133691B1 Device for organic cell culture and for studying their electrophysiological activity and membrane used in said device |
| 04/02/2003 | EP1084268B1 Biotechnological production of polyglutaminic acid |
| 04/02/2003 | EP0774513B1 RECOMBINANT HERPESVIRUS WITH THE USE OF gB GENE PROMOTER |
| 04/02/2003 | EP0758385B1 Chimeric delta-endotoxin expression in pseudomonas fluorescens |
| 04/02/2003 | EP0742820B1 Production of pharmaceutical-grade plasmid dna |
| 04/02/2003 | EP0716697B1 DIFFERENTIALLY EXPRESSED $i(LEISHMANIA) GENES AND PROTEINS |
| 04/02/2003 | EP0700444B1 Immunotoxins comprising gelonin and an antibody |
| 04/02/2003 | EP0677114B1 Recombinant swinepox virus |
| 04/02/2003 | EP0673427B1 Enzymatic process using enzymes immobilized on the cell wall of a eukaryotic microbial cell by producing a fusion protein |
| 04/02/2003 | EP0621865B1 Rapamycin derivative and its medicinal use |
| 04/02/2003 | EP0610427B1 Tgf-beta type iii receptor, cdna encoding it and uses therefor |
| 04/02/2003 | EP0561890B1 Dna expression systems based on alphaviruses |
| 04/02/2003 | CN1408025A Method and compositions for improved polynucleotide synthesis |
| 04/02/2003 | CN1408023A Pesticidal proteins |
| 04/02/2003 | CN1104502C Genes encoding branched-chain alpha-Ketoacid dehydrogenase complex from streptomyces avermitilis |
| 04/02/2003 | CN1104501C Modified human C3 proteins |
| 04/02/2003 | CN1104440C Method for variation of chromatin condensation |
| 04/02/2003 | CN1104235C Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans |
| 04/01/2003 | US6541623 Sepsis shock therapy; rheumatic diseases; antiinflammatory agents; nucleotide sequence detector |
| 04/01/2003 | US6541620 Antagonist for tumor necrosis factor; antiinflammatory agents; rheumatic diseases |
| 04/01/2003 | US6541616 Exterior membrane; nucleotide sequence; induction immunology response |
| 04/01/2003 | US6541612 Complex of rapamycin-42 ester with dicarboxylic acid and fluorescein; antibody detection/generation; immunoglobulins; hybridomas; ring opening; precipitation |
| 04/01/2003 | US6541457 Mammalian IAP gene family, primers, probes and detection methods |
| 04/01/2003 | US6541255 Engraftable human neural stem cells |
| 04/01/2003 | US6541246 Method for detecting and for quantifying adenoviruses |
| 04/01/2003 | US6541239 From L-sorbose, using pure culture of microorganisms which has been transformed with linear or circular DNA |
| 04/01/2003 | US6541233 β-glucanase from a bacillus |
| 04/01/2003 | US6541215 Quantitative determination method of mannose and reagent therefor |
| 04/01/2003 | US6541049 Method for production of arachidonic acid |
| 04/01/2003 | US6541027 Lactic acid bacteria with anxiolytic properties and uses thereof |
| 04/01/2003 | US6541010 Alphavirus RNA replicon systems |
| 04/01/2003 | US6540992 Elk ligand (Elk-L) where elk is a member of the tyrosine kinase receptor family; protects against excitotoxicity, especially of the hipocammpal neurons |
| 04/01/2003 | CA2235951C Novel uses of mammalian ctla-8 and related reagents |
| 04/01/2003 | CA2109584C Method for production of a whey protein hydrolyzate |
| 04/01/2003 | CA2102129C Growth hormone antagonists |
| 04/01/2003 | CA2101070C Antigen-presenting capsid with fusion ms2-coat protein |
| 04/01/2003 | CA1341426C Process for the manufacture of thrombin inhibitors |
| 03/27/2003 | WO2003025193A1 Plant enzymes for bioconversion |
| 03/27/2003 | WO2003025182A1 Dna for overexpression of growth hormone and utilization thereof |
| 03/27/2003 | WO2002083870A3 Pufa polyketide synthase systems and uses thereof |
| 03/27/2003 | WO2002070717A3 Nitrile hydratase and a method for producing amides |
| 03/27/2003 | US20030060616 Type II IL-1 receptors |
| 03/27/2003 | US20030059925 Fermentation medium and method |
| 03/27/2003 | US20030059914 Microorganismal culture for use in the generation of transglutaminases; for use in food processing and cosmetics |
| 03/27/2003 | US20030059872 Nucleotide sequences coding polypeptide for use as diagnostic tools in genetic engineering |
| 03/27/2003 | US20030059867 Isolation and cultivation of microorganisms from natural environments and drug discovery based thereon |
| 03/27/2003 | US20030059845 Novel human dopamine receptor and its uses |
| 03/27/2003 | US20030059442 Attenuated microorganisms for the treatment of infection |
| 03/27/2003 | US20030058780 Disk device |
| 03/26/2003 | EP1296142A2 Calcium receptor active molecules |
| 03/26/2003 | EP1295952A2 Methods for screening for transdominant effector peptides and RNA molecules |
| 03/26/2003 | EP1295945A1 Human neuronal nictinic acetylcholine receptor compositions and mehtods employing same |
| 03/26/2003 | EP1295944A2 GDP dissociation stimulating protein, brain-specific nucleosome assembly protein, skeletal muscle specific ubiquitin-conjugating enzyme, cell proliferation protein, phosphatidylinositolkinase, nel related proteins |